APPLICATION
ANDA215096
TYPE
ANDA
ORIGINAL APPROVAL
2026-02-02
LATEST ACTION
2026-02-02
ROUTE
TRANSDERMAL
DOSAGE FORM
GEL, METERED
MARKETING STATUS
Discontinued
Products
ESTRADIOLDiscontinued
ESTRADIOL 0.06% (1.25GM/ACTIVATION) · GEL, METERED · TRANSDERMAL
Approval history
2026-02-02UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.